Christopher Hoppe

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

IONpath, Inc. transforms pathology with multiplexed ion beam imaging. The company was founded by Michael Angelo, Sean Bendall, Harris Fienberg and Gerry Noland and is headquartered in San Mateo, CA.

Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom.

Paladin Capital Group (Paladin Capital) is a private equity subsidiary of Penn Ave Investments LLC founded by Mark Maloney and Michael Steed in 2001. The firm is headquartered in Washington, DC with offices in New York City, Silicon Valley, London and Luxembourg.

BRAINBox Solutions, Inc. develops and manufactures tools for diagnosing mild traumatic brain injuries. It specializes in concussion, neurological biomarkers, point of care, neurocognitive testing, and diagnosis. The company was founded in 2018 and is headquartered in Richmond, VA.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

Epitel, Inc. is a digital health company based in Salt Lake City, UT. Epitel, Inc. revolutionizes how brain health is monitored by combining wearable EEG technology with data analytics and machine-learning capabilities. The company designs and develop wireless solutions that provide long-term monitoring for people living with epilepsy. The company's proprietary cloud-based wearable sensor system, along with other innovative AI technologies, empowers better treatment decisions by making EEG readily deployable and accessible. Epitel's flagship product, Remi, is an unobtrusive wearable seizure detection system that records long-term EEG, providing peace of mind and better understanding for individuals managing their seizures. The company was founded by Mark Lehmkuhle and he has been the CEO since incorporation.

Lam Capital is a private equity subsidiary of Lam Research Corp founded in 2017 by Faran Nouri. The firm is headquartered in Fremont, California.

Labcyte, Inc. operates as a biotechnology tools company that manufactures and markets echo liquid handling systems. It offers liquid handling, automation and consumables. The company was founded by Richard Nathan Ellson and Mark D. Fischer-Colbrie and A. Mark Bramwell in October 2003 and is headquartered in Sunnyvale, CA.

Magnolia Medical Technologies, Inc. develops medical devices that focus on improving the accuracy of diagnostic blood culture tests. The company was founded by Gregory J. Bullington and Richard G. Patton and is headquartered in Seattle, WA.

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands.

ProDigest BVBA provides customized solutions related to gastrointestinal research, bioavailability and metabolism. The firm serves the operators in the market of food, functional food, feed and pharmaceutical industry. The company was founded by Sam Possemiers, Massimo Marzorati and Massimo Marzorati on September 24, 2008 and is headquartered in Ghent, Belgium.

Triple Ring Technologies, Inc. operates as an imaginative research and development firm. It works across the development process in regulated markets including medical devices, in vitro diagnostics and life science tools, imaging and industrial applications. The company was founded in February 2005 and is headquartered in Newark, CA.

ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA.

Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France.

Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country.

Lavorel Medicare SA provides medical home care services. The firm provides nursing care and ambulatory services at home. The company was founded by Jean-Claude Lavorel and Stanislas Lavorel in 2012 and is headquartered in Luxembourg.

Pharmacelera SL engages in providing hardware and software solution services for pharm screen and pharmQSAR. Its products include pharmScreen, phramQSAP and phramaBox. The company was founded by Enric Herrero Abellanas and Enric Gibert Codina and is headquartered in Barcelona, Spain.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Preferred Global Health, Inc. provides medical care services. The company was founded by Paul L. Eckbo and is headquartered in Boston, MA.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz.